Specificity of basolateral organic anion exchanger in proximal tubule for cellular and extracellular solutes.
We used an epifluorimetric technique to study the mechanism of organic anion transport across the basolateral surface of isolated S2 segments of rabbit proximal tubules. Fluorescein influx and efflux rates across the basolateral surface of lumen-collapsed tubules were determined from serial measurements of cellular fluorescein content after its addition to or removal from the bathing medium. We examined the effect on fluorescein transport of monocarboxylic and dicarboxylic metabolic intermediates added to the bathing medium or preloaded into the cells. The presence of the monocarboxylates (octanoate, valerate, butyrate, propionate, and acetate) in the bathing medium inhibited fluorescein influx. The eight-carbon-chain fatty acid, octanoate, was nearly as potent an inhibitor as probenecid and was more potent than p-aminohippurate (PAH) (IC50 = 10, 6, and 141 microM, respectively); the shorter chain fatty acids were much less effective (IC50 greater than or equal to 1,000 microM). The dicarboxylates (succinate, adipate, and alpha-ketoglutarate) moderately inhibited fluorescein influx (IC50 = 505, 245, and 257 microM, respectively). To determine the effect of intracellular organic anions on fluorescein influx, tubules were preincubated with organic anions to load the cells; the compounds were then removed from the bath, and fluorescein influx was measured. Preincubation with monocarboxylates, octanoate, butyrate, acetate, and PAH had no effect. In contrast, the dicarboxylates alpha-ketoglutarate, glutarate, and adipate stimulated fluorescein influx by 58, 53, and 43%, respectively, but succinate had no effect. Fluorescein efflux was accelerated by medium octanoate, PAH, alpha-ketoglutarate, and succinate but not by acetate. Probenecid alone had no effect on fluorescein efflux, but it blocked the stimulation caused by medium PAH.(ABSTRACT TRUNCATED AT 250 WORDS)
Sullivan
L P
LP
Department of Physiology, University of Kansas Medical Center, Kansas City 66103.
Grantham
J J
JJ
D000818:Animals; D027321:Anion Transport Proteins; D001692:Biological Transport / Q000187:drug effects; D002352:Carrier Proteins / Q000378:metabolism*; D003998:Dicarboxylic Acids / Q000494:pharmacology; D005227:Fatty Acids / Q000494:pharmacology; D005260:Female; D019793:Fluorescein; D005452:Fluoresceins / Q000378:metabolism; D007687:Kidney Tubules, Proximal / Q000378:metabolism*; D008954:Models, Biological; D011339:Probenecid / Q000494:pharmacology; D011817:Rabbits; D013379:Substrate Specificity; D010130:p-Aminohippuric Acid / Q000378:metabolism / Q000494:pharmacology
D027321:Anion Transport Proteins; D002352:Carrier Proteins; D003998:Dicarboxylic Acids; D005227:Fatty Acids; D005452:Fluoresceins; D011339:Probenecid; D019793:Fluorescein; D010130:p-Aminohippuric Acid